Your browser doesn't support javascript.
loading
Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
Mc Gettigan, Neasa; Boland, Karen; O'Toole, Aoibhlinn.
Affiliation
  • Mc Gettigan N; Gastroenterology Department, Beaumont Hospital, Dublin 9, Ireland, D09V2N0 and School of Medicine, Royal College of Surgeons, 123 St Stephen's Green, Dublin 2, Ireland.
  • Boland K; Gastroenterology Department, Beaumont Hospital, Dublin 9, Ireland, D09V2N0 and School of Medicine, Royal College of Surgeons, 123 St Stephen's Green, Dublin 2, Ireland.
  • O'Toole A; Gastroenterology Department, Beaumont Hospital, Dublin 9, Ireland, D09V2N0 and School of Medicine, Royal College of Surgeons, 123 St Stephen's Green, Dublin 2, Ireland.
Inflamm Bowel Dis ; 28(5): e59-e60, 2022 05 04.
Article in En | MEDLINE | ID: mdl-35512142

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: Ireland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: Ireland Country of publication: United kingdom